Similar Papers

Paper Title
Journal
Date
Author
MPC‐1−CD49e− immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL‐6 in human myelomas
Ryuichi Fujii ... Hideki Asaoku
British Journal of Haematology | VOL. 105
Ryuichi Fujii, et. al.Ryuichi Fujii ... Hideki Asaoku
01 Apr 1999
Growth mechanism of human myeloma cells by interleukin-6.
Michio M Kawano ... Fu-Jun Li
International journal of hematology | VOL. Suppl 76 1
Michio M Kawano, et. al.Michio M Kawano ... Fu-Jun Li
01 Jan 2002
Proliferation of Immature Myeloma Cells by Interleukin-6 Is Associated with CD45 Expression in Human Multiple Myeloma
Hideaki Ishikawa ... Michio M Kawano
Leukemia & Lymphoma | VOL. 39
Hideaki Ishikawa, et. al.Hideaki Ishikawa ... Michio M Kawano
01 Jan 1999
Derivation and Drug Screening of Growth Factors- and Stroma-Dependent Human Multiple Myeloma Cells
Jae-Hung Shieh ... Malcolm A.S Moore
Blood | VOL. 120
Jae-Hung Shieh, et. al.Jae-Hung Shieh ... Malcolm A.S Moore
16 Nov 2012
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies.
Dennis L Cooper ... Amit Verma
British journal of haematology | VOL. -
Dennis L Cooper, et. al.Dennis L Cooper ... Amit Verma
06 Feb 2025
Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML.
John Chadwick ... Emma Searle
British journal of haematology | VOL. -
John Chadwick, et. al.John Chadwick ... Emma Searle
30 Jan 2025
T-cell-based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic.
S Moraru ... Laure Ricard
British journal of haematology | VOL. -
S Moraru, et. al.S Moraru ... Laure Ricard
29 Jan 2025
First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory.
Tanya M Wildes
British journal of haematology | VOL. -
Tanya M WildesTanya M Wildes
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.